Get Adakveo at BioHealth Infusion Center
About Adakveo
Adakveo (crizanlizumab-tmca) is used in people with sickle cell disease to help reduce how often pain crises, also known as “vaso-occlusive crises,” happen.
Vaso-occlusive crises (VOCs) occur when micro circulation is obstructed by “sickled” red blood cells. Adakveo works by binding to P-selectin, a protein that plays a central role in cellular interactions that can lead to vaso-occlusion. In its initial study, Adakveo was shown to reduce VOCs by about 45%.
Getting Your Adakveo Infusion
Adakveo is given every 4 weeks after two starter doses. Each intravenous infusion takes about 30 minutes.
Manufacturer:
First Approval:
Novartis
11/15/2019
Get Adakveo at BioHealth Infusion Center and enjoy:
Perfect Medical Services
Schedule an Appointment
Our goal is to provide patients with courteous, prompt, and experienced infusion care. With just one phone call to the infusion center, the authorization process can begin immediately. All reimbursement and financial assistance options are explored in order to provide the patient’s infusion therapy at the lowest out-of-pocket costs to them.